Transferrin-functionalized lipid nanoparticles for curcumin brain delivery
[Display omitted] •Curcumin-loaded lipid nanoparticle functionalized with transferrin was developed.•No cytotoxicity of nanoparticles was detected in hCMEC/D3 cell line.•Transferrin-nanoparticles enhance permeability across blood-brain barrier.•Great potential for neuroprotection. Curcumin is an ant...
Gespeichert in:
Veröffentlicht in: | Journal of biotechnology 2021-04, Vol.331, p.108-117 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•Curcumin-loaded lipid nanoparticle functionalized with transferrin was developed.•No cytotoxicity of nanoparticles was detected in hCMEC/D3 cell line.•Transferrin-nanoparticles enhance permeability across blood-brain barrier.•Great potential for neuroprotection.
Curcumin is an anti-inflammatory and antioxidant compound with potent neuroprotective activity. Due to its poor water solubility, low bioavailability, rapid elimination and the challenges for crossing and transposing the blood-brain barrier (BBB), solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) loaded with curcumin were successfully produced and functionalized with transferrin, in order to mediate the transport of these particles through the BBB endothelium to the brain.
The nanosystems revealed Z-averages under 200 nm, polydispersity index below 0.2 and zeta potential around -30 mV. Curcumin encapsulation around 65 % for SLNs and 80 % for NLCs was accomplished, while the functionalized nanoparticles presented a value around 70–75 %. A stability study revealed these characteristics remained unchanged for at least 3 months. hCMEC/D3 cells viability was firstly analysed by MTT and LDH assays, respectively, and a concentration of 10 μM of curcumin-loaded nanoparticles were then selected for the subsequent permeability assay. The permeability study was conducted using transwell devices with hCMEC/D3 cells monolayers and a 1.5-fold higher permeation of curcumin through the BBB was verified. Both SLNs and NLCs are promising for curcumin brain delivery, protecting the incorporated curcumin and targeting to the brain by the addition of transferrin to the nanoparticles surface. |
---|---|
ISSN: | 0168-1656 1873-4863 |
DOI: | 10.1016/j.jbiotec.2021.03.010 |